Zymeworks Inc.
corporate_fare Company Profile
Zymeworks Inc. (NASDAQ:ZYME) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for ZYME at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Zymeworks Appoints Kristin Stafford as Executive VP & CFO, Strengthening Financial Leadership
- FDA Grants Fast Track to Zymeworks' ZW191 for Ovarian Cancer, Accelerating Development
- Zymeworks Secures $250M Non-Recourse Royalty Financing from Royalty Pharma, Extends Cash Runway
- Zymeworks Secures $250M Non-Dilutive Financing, Reports Strong 2025 Results, and Advances Key Pipeline Assets
- Zymeworks Reports Strong FY25 Results, Secures $250M Non-Dilutive Financing, and Advances Lead Asset Towards US Launch
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$105.97M
Net Income
-$81.13M
Diluted EPS
-$1.08
Op. Cash Flow
-$33.01M
Free Cash Flow
-$34.53M
Operating Income
-$92.55M
Cash & Equivalents
$41.16M
Debt / Equity
0.00×
Net Margin
-76.6%
Shares Outstanding
74.64M sh
Source: 10-K · filed 2026-03-02 · accession 0001937653-26-000015
show_chartPrice Chart
Loading chart...
feed ZYME - Filings & News (Page 2)
ZYME
Apr 01, 2026, 6:16 AM EDT
Price at Filing:
$24.99
Real-time Price:
$26.14
Change:
+$1.15 (+5%)
Market Cap:
$1.81B
ZYME
Mar 30, 2026, 6:00 AM EDT
Price at Filing:
$24.90
Real-time Price:
$26.14
Change:
+$1.24 (+5%)
Market Cap:
$1.81B
ZYME
Mar 02, 2026, 6:28 AM EST
Price at Filing:
$23.40
Real-time Price:
$26.14
Change:
+$2.74 (+12%)
Market Cap:
$1.81B
ZYME
Mar 02, 2026, 6:28 AM EST
Price at Filing:
$23.40
Real-time Price:
$26.14
Change:
+$2.74 (+12%)
Market Cap:
$1.81B
ZYME
Mar 02, 2026, 6:03 AM EST
Price at Filing:
$23.40
Real-time Price:
$26.14
Change:
+$2.74 (+12%)
Market Cap:
$1.81B
ZYME
Mar 02, 2026, 6:00 AM EST
Price at Filing:
$23.40
Real-time Price:
$26.14
Change:
+$2.74 (+12%)
Market Cap:
$1.81B
ZYME
Jan 12, 2026, 4:34 PM EST
Price at Filing:
$23.16
Real-time Price:
$26.14
Change:
+$2.98 (+13%)
Market Cap:
$1.81B